共 32 条
[1]
Vijayaraghavan A(2008)Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa Gynecol Oncol 112 377-83
[2]
Efrusy M(1998)Pap smear utilization in Canada: Estimates after adjusting the eligible population for hysterectomy status Chron Dis Can 19 19-24
[3]
Lindeque G(1998)Natural history of cervico-vaginal papillomavirus infection in young women N Engl J Med 338 423-28
[4]
Dreyer G(2005)Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, the Netherlands, France, and Italy J Natl Cancer Inst 97 888-95
[5]
Santas C(2000)Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis Am J Epidemiol 151 1158-71
[6]
Snider JA(2003)Cost-effectiveness of a potential vaccine for human papillomavirus Emerg Infect Dis 9 37-48
[7]
Beauvais JE(2003)Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance Am J Obstet Gynecol 188 1383-92
[8]
Ho GY(2007)Modeling human papillomavirus vaccine effectiveness: Quantifying the impact of parameter uncertainty Am J Epidemiol 165 762-75
[9]
Bierman R(2008)Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination J Natl Cancer Inst 100 308-20
[10]
Beardsley L(2008)Cervical cancer screening following prophylactic human papillomavirus vaccination Vaccine 26 A16-A23